trinitrobenzenesulfonic acid has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, T; Ishizaki, M; Maeda, H; Matsuda, T; Muromoto, R; Ohshiro, Y; Oritani, K; Sekine, Y; Shimoda, K; Yokoyama, M | 1 |
| Contractor, N; Fuss, I; Hoffmann, V; Iwaki, S; Kelsall, BL; la Sala, A; Lahey, E; Leon, F; Marth, T; Strober, W | 1 |
2 other study(ies) available for trinitrobenzenesulfonic acid and Psoriasis
| Article | Year |
|---|---|
Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Differentiation; Colitis; Dextran Sulfate; Drug Delivery Systems; Hypersensitivity, Delayed; Imiquimod; Interleukin-12; Interleukin-23; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Psoriasis; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid; TYK2 Kinase | 2011 |
Antibodies to complement receptor 3 treat established inflammation in murine models of colitis and a novel model of psoriasiform dermatitis.
Topics: Adoptive Transfer; Animals; Antibodies; CD4-Positive T-Lymphocytes; Cells, Cultured; Colitis; Dermatitis; Disease Models, Animal; Female; Inflammation Mediators; Injections, Intravenous; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Psoriasis; Trinitrobenzenesulfonic Acid | 2006 |